The haemoflagellate protozoan Trypanosoma cruzi (T. cruzi) is the causative agent of Chagas disease (CD), a potentially life-threatening disease. Little by little, remarkable progress has been achieved against CD, although it is still not enough. In the absence of effective chemotherapy, many research groups, organizations and pharmaceutical companies have focused their efforts on the search for compounds that could become viable drugs against CD. Within the wide variety of reported derivatives, this review summarizes and provides a global vision of the situation of those compounds that include broadly studied heterocycles in their structures due to their applications in medicinal chemistry: imidazole and benzimidazole rings. Therefore, the intention of this work is to present a compilation, as much as possible, of all the reported information, regarding these imidazole and benzimidazole derivatives against T. cruzi, as a starting point for future researchers in this field.
Keywords: 6-Phospho-1-fructokinase; Benzimidazole; Chagas disease; Cruzain; Farnesyltransferase; Heterocycles; Imidazole; Sterol 14α-demethylase; Superoxide dismutase; Triosephosphate isomerase; Trypanosoma cruzi.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.